type 2 diabetes
Ozempic Launches in India: Novo Nordisk's Diabetes and Weight Loss Drug Enters World's Second-Largest Diabetes Market
Dec 12, 2025 05:46 pm CST
Novo Nordisk has introduced Ozempic to the Indian market, pricing the diabetes medication at Rs 8,800-11,175 monthly across three dosages. The strategic launch targets India's significant diabetic population before generic competitors arrive in 2026. Beyond blood sugar control, Ozempic offers weight loss benefits and reduced cardiovascular risks, but remains prescription-restricted for medical use only.
IIT Bombay Discovers Biomarkers for Early Detection of Diabetic Kidney Disease: A Breakthrough in Personalized Treatment
Nov 04, 2025 11:10 pm CST
Researchers from IIT Bombay have identified specific blood biomarkers that can detect early signs of kidney disease in diabetic patients, potentially revolutionizing diagnosis and treatment approaches. The study found 26 metabolites differentiating diabetic patients from healthy individuals and revealed distinct metabolic subgroups among patients. This breakthrough could lead to personalized treatment strategies in India, where 101 million adults have diabetes and one-third develop kidney complications.
Rising Diabetes In US Kids: Can Mounjaro Be The Answer? New Study Says Yes
Sep 20, 2025 05:21 pm CST
A new study reveals Mounjaro may help children as young as 10 manage Type 2 diabetes, significantly reducing blood sugar and weight, with Eli Lilly pushing to expand its use beyond adults.